Best of K‑CONNECT Summit 2026: Translating Multi-omics and AI Into Real-World Precision Oncology
At the K-CONNECT Summit 2026 in Da Nang, more than 250 international experts attended onsite, while over 1,000 participants joined online to explore how multi-omics, liquid biopsy, and Artificial Intelligence (AI) can be translated into clinical practice in ways that are useful and scalable for patients. During the Academic Day, held under the theme “AI […]
Gene Solutions Malaysia and National Cancer Society Malaysia Join Forces to Expand Access to Multi-Cancer Detection Through Early4Life Initiative
Close to 300 SPOT-MAS 10 tests delivered to communities and frontline institutions, including MINDEF and PDRM Bukit Aman Kuala Lumpur, Malaysia — 15th June 2026 — Gene Solutions Malaysia, in collaboration with the National Cancer Society of Malaysia (NCSM), has expanded access to blood-based multi-cancer detection through the Early4Life initiative, reaching communities and frontline institutions across […]
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test SINGAPORE, 28 May 2026 — Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi–omics blood test designed to detect cancer–associated […]
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
TAIPEI, May 22, 2026 — Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer Conference (TJCC 2026), marking its first major oncology conference presence in Taiwan. The company’s satellite symposium and exhibition booth facilitated scientific exchange with the local oncology community on the […]
Single-Gene Disorders. Lifelong Impact. Early Screening Matters.
8 May marks World Thalassemia Day — a global moment to honor families living with thalassemia and raise awareness of inherited blood disorders. In 2026, the global campaign theme, “Hidden No More: Finding the Undiagnosed. Supporting the Unseen,” reminds us that early awareness and access to screening can help bring silent genetic risks into view (1). Thalassemia is one of […]
K-CONNECT SUMMIT 2026: Advancing AI, Multi-Omics, and Precision Oncology Across Asia-Pacific
K-CONNECT SUMMIT 2026, co-hosted by Gene Solutions, the Vietnam Institute of Clinical Medicine and Pharmacy, and the Vietnam Medical Association, will convene oncologists, healthcare professionals, researchers, and international experts to advance scientific exchange in early cancer detection and precision oncology. Following the success of K-CONNECT APAC 2025, which brought together more than 100 oncologists and molecular experts from nine Asia-Pacific countries, […]
Gene Solutions Introduces Dual Tumor-Blood Liquid Biopsy Comprehensive Profiling Upgrades for K-TRACK and K-4CARE
Deeper molecular insights, with faster turn-around time, for sooner decisions across the patient journey Singapore, 30 April 2026 — Gene Solutions has announced major upgrades to their K-TRACK and K-4CARE portfolios, reinforcing their commitment to making precision oncology more practical and more accessible in real-world care. With more than 20,000 K-TRACK, K-4CARE tests performed across leading […]
Gene Solutions is accelerating access to advanced genetic testing in India through its strategic collaboration with Genique Lifesciences
We’re pleased to share that, through our strategic collaboration with Genique Lifesciences, we are expanding access to advanced AI-enabled genomic testing in India — bringing genomic insights closer to clinical practice across oncology and reproductive health. By combining Gene Solutions’ strengths in AI-powered genomics and liquid biopsy with Genique Lifesciences’ strong clinical network in India, […]
Gene Solutions Expands SPOT-MAS Portfolio with Accessible Cancer Screening and Precision Triage Solutions
April 20, 2026 — Gene Solutions announced the expansion of its SPOT‑MAS portfolio with two new solutions: SPOT-MAS CRC and SPOT-MAS Eva. These additions bring accessible blood-based colorectal cancer screening and molecular precision triage for cervical and endometrial cancers. Building on its leadership in cell-free DNA, cancer epigenetics, and AI-powered multi-omics, Gene Solutions continues to advance […]
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
All-in-one approach integrates chromosomal analysis, single-gene disorder screening, and maternal carrier screening from a single blood draw. TAIPEI, April 14, 2026 /PRNewswire/ — At the prestigious Taiwan Association of Obstetrics and Gynecology (TAOG) 2026 Annual Meeting—the nation’s largest obstetrics and gynecology society established in 1961— Gene Solutions Taiwan officially introduced triSure, a revolutionary non-invasive prenatal screening technology. This marks a definitive shift in […]